ATCOR develops and markets medical technologies that measure patient risk for hypertension, cardiovascular disease (CVD), and other related vascular disorders. We help clinicians with early detection of target organ damage and management of cardiovascular and renal disease.
Our SphygmoCor® technology enables researchers and clinicians to measure noninvasive central blood pressure (NcBP), arterial stiffness, vascular age, and other unique cardiovascular parameters. Central arterial pressure waveform analysis provides clinicians with better prognostic and diagnostic information to target interventions—effects which cannot be detected with standard brachial blood pressure measurement alone.
More than 4,000 SphygmoCor® systems are currently in use worldwide at major medical institutions, research institutions, and in various clinical trials with leading pharmaceutical companies. Our technology is featured in over 1,400 peer-reviewed publications in leading medical journals.
ATCOR-X and the Internet of Medical Things (IoMT)
Under the ATCOR-X brand, we also develop and license our Arty™ platform consisting of physiological and health analytics for wearable and connected fitness devices. Our digital platform, ArtyNet™, is a connected SaaS ecosystem providing physicians with a complete telehealth solution for remotely managing patients’ health (2021 launch).
ATCOR is a subsidiary of the Australian listed company CardieX Limited (ASX.CDX) www.cardiex.com
World-First Platform for Heart and Arterial Health
- ATCOR-X is a world-first feature set of unique, medically reliable biometric heart and arterial health measurements not available anywhere else.
- Arty™ is an IoMT ecosystem of connected devices & apps designed to improve daily wellbeing and long-term health.
- ATCOR-X offers a new approach to vital signs monitoring—based on central blood pressure waveform analysis from our FDA-cleared SphygmoCor® technology—the global gold standard for noninvasive measurement of central blood pressure and arterial stiffness.
Breakthrough technology for monitoring heart and arterial health with wearable devices.